Can Bulls Push $JNJ Stock Above $252?

$Johnson & Johnson(JNJ)$

$Johnson & Johnson (JNJ) Climbs +1.61%: Healthcare Titan Gains Momentum, Eyes $254 Target

📈 Latest Close:

JNJ closed at $244.88 (+1.61%) on 6/26, now just 2.7% away from its 52-week high of $251.71.

🚀 Core Market Drivers:

Positive momentum is fueled by a favorable court ruling that halved talc-related damages to $2.1B, easing litigation overhang. Analyst sentiment remains strong, with Leerink Partners recently upgrading the stock to Outperform.

📊 Technical Analysis:

Volume was 10.13M (Volume Ratio: 0.90). The MACD is bullish at 1.88, showing strong upward momentum. The RSI(6) is at 73.64, indicating overbought conditions in the short term, suggesting potential for a brief consolidation.

🎯 Key Price Levels:

Immediate Pivot: $244.14 (Recent Resistance)
Primary Support: $223.33
Strong Resistance: $251.71 (52-Week High)

💰 Valuation:

TTM P/E stands at 28.36, which is elevated compared to its historical forward P/E average of 16.35, indicating high expectations are priced in.

🎯 Analyst Targets:

24 analysts cover JNJ with an average price target of $254.05. The consensus is bullish, with 6 Strong Buy, 12 Buy, and 9 Hold ratings.

🔮 Weekly Outlook:

Expect consolidation near current levels with a $240 - $252 range. A decisive break above $251.71 could target the $254-$260 zone. A drop below $240 may test the $233 support.

⚠️ Risk Disclaimer:

This analysis is for informational purposes only and not investment advice. Past performance does not guarantee future results. Always conduct your own research and consider your risk tolerance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

81

3

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":579376735567992,"tweetId":"579376735567992","gmtCreate":1782480155270,"gmtModify":1782480636250,"author":{"id":3527667678950622,"idStr":"3527667678950622","authorId":3527667678950622,"authorIdStr":"3527667678950622","name":"Trend_Radar","avatar":"https://community-static.tradeup.com/news/731342fb346b158cb8d15a31d1ec16d1","vip":8,"userType":8,"introduction":"-","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1528,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/6765e9c98200da5326457d66b152b132","width":"560","height":"240"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/6765e9c98200da5326457d66b152b132","width":"560","height":"240"}],"title":"Can Bulls Push $JNJ Stock Above $252?","html":"<html><head></head><body><h2 style=\"text-align: left;\"><a data-mention-id=\"JNJ\" rel=\"noopener noreferrer\" class=\"teditor-mention\" data-mention-name=\"Johnson &amp; Johnson\" target=\"_blank\" href=\"https://ttm.financial/S/JNJ\">$Johnson &amp; Johnson(JNJ)$</a></h2>\n<h3 style=\"text-align: left;\"><strong>$Johnson &amp; Johnson (JNJ) Climbs +1.61%: Healthcare Titan Gains Momentum, Eyes $254 Target</strong></h3>\n<p class=\"t-img-caption\"><img data-align=\"center\" data-image-type=\"kline\" src=\"https://community-static.tradeup.com/news/6765e9c98200da5326457d66b152b132\" tg-width=\"560\" tg-height=\"240\"><span></span></p>\n<p style=\"text-align: left;\"><strong>📈 Latest Close:</strong></p>\n<p style=\"text-align: left;\">JNJ closed at <strong>$244.88</strong> (+1.61%) on 6/26, now just <strong>2.7%</strong> away from its 52-week high of $251.71.</p>\n<p style=\"text-align: left;\"><strong>🚀 Core Market Drivers:</strong></p>\n<p style=\"text-align: left;\">Positive momentum is fueled by a favorable court ruling that <strong>halved talc-related damages to $2.1B</strong>, easing litigation overhang. Analyst sentiment remains strong, with Leerink Partners recently upgrading the stock to <strong>Outperform</strong>.</p>\n<p style=\"text-align: left;\"><strong>📊 Technical Analysis:</strong></p>\n<p style=\"text-align: left;\">Volume was <strong>10.13M</strong> (Volume Ratio: 0.90). The <strong>MACD</strong> is bullish at <strong>1.88</strong>, showing strong upward momentum. The <strong>RSI(6)</strong> is at <strong>73.64</strong>, indicating overbought conditions in the short term, suggesting potential for a brief consolidation.</p>\n<p style=\"text-align: left;\"><strong>🎯 Key Price Levels:</strong></p>\n<ul>\n <li>\n  <p style=\"text-align: left;\"><strong>Immediate Pivot:</strong> $244.14 (Recent Resistance)</p></li>\n <li>\n  <p style=\"text-align: left;\"><strong>Primary Support:</strong> $223.33</p></li>\n <li>\n  <p style=\"text-align: left;\"><strong>Strong Resistance:</strong> $251.71 (52-Week High)</p></li>\n</ul>\n<p style=\"text-align: left;\"><strong>💰 Valuation:</strong></p>\n<p style=\"text-align: left;\">TTM P/E stands at <strong>28.36</strong>, which is elevated compared to its historical forward P/E average of <strong>16.35</strong>, indicating high expectations are priced in.</p>\n<p style=\"text-align: left;\"><strong>🎯 Analyst Targets:</strong></p>\n<p style=\"text-align: left;\"><strong>24 analysts</strong> cover JNJ with an average price target of <strong>$254.05</strong>. The consensus is bullish, with <strong>6 Strong Buy, 12 Buy, and 9 Hold</strong> ratings.</p>\n<p style=\"text-align: left;\"><strong>🔮 Weekly Outlook:</strong></p>\n<p style=\"text-align: left;\">Expect <strong>consolidation</strong> near current levels with a <strong>$240 - $252</strong> range. A decisive break above <strong>$251.71</strong> could target the <strong>$254-$260</strong> zone. A drop below <strong>$240</strong> may test the $233 support.</p>\n<p style=\"text-align: left;\"><strong>⚠️ Risk Disclaimer:</strong></p>\n<p style=\"text-align: left;\"><em>This analysis is for informational purposes only and not investment advice. Past performance does not guarantee future results. Always conduct your own research and consider your risk tolerance.</em></p></body></html>","htmlText":"<html><head></head><body><h2 style=\"text-align: left;\"><a data-mention-id=\"JNJ\" rel=\"noopener noreferrer\" class=\"teditor-mention\" data-mention-name=\"Johnson &amp; Johnson\" target=\"_blank\" href=\"https://ttm.financial/S/JNJ\">$Johnson &amp; Johnson(JNJ)$</a></h2>\n<h3 style=\"text-align: left;\"><strong>$Johnson &amp; Johnson (JNJ) Climbs +1.61%: Healthcare Titan Gains Momentum, Eyes $254 Target</strong></h3>\n<p class=\"t-img-caption\"><img data-align=\"center\" data-image-type=\"kline\" src=\"https://community-static.tradeup.com/news/6765e9c98200da5326457d66b152b132\" tg-width=\"560\" tg-height=\"240\"><span></span></p>\n<p style=\"text-align: left;\"><strong>📈 Latest Close:</strong></p>\n<p style=\"text-align: left;\">JNJ closed at <strong>$244.88</strong> (+1.61%) on 6/26, now just <strong>2.7%</strong> away from its 52-week high of $251.71.</p>\n<p style=\"text-align: left;\"><strong>🚀 Core Market Drivers:</strong></p>\n<p style=\"text-align: left;\">Positive momentum is fueled by a favorable court ruling that <strong>halved talc-related damages to $2.1B</strong>, easing litigation overhang. Analyst sentiment remains strong, with Leerink Partners recently upgrading the stock to <strong>Outperform</strong>.</p>\n<p style=\"text-align: left;\"><strong>📊 Technical Analysis:</strong></p>\n<p style=\"text-align: left;\">Volume was <strong>10.13M</strong> (Volume Ratio: 0.90). The <strong>MACD</strong> is bullish at <strong>1.88</strong>, showing strong upward momentum. The <strong>RSI(6)</strong> is at <strong>73.64</strong>, indicating overbought conditions in the short term, suggesting potential for a brief consolidation.</p>\n<p style=\"text-align: left;\"><strong>🎯 Key Price Levels:</strong></p>\n<ul>\n <li>\n  <p style=\"text-align: left;\"><strong>Immediate Pivot:</strong> $244.14 (Recent Resistance)</p></li>\n <li>\n  <p style=\"text-align: left;\"><strong>Primary Support:</strong> $223.33</p></li>\n <li>\n  <p style=\"text-align: left;\"><strong>Strong Resistance:</strong> $251.71 (52-Week High)</p></li>\n</ul>\n<p style=\"text-align: left;\"><strong>💰 Valuation:</strong></p>\n<p style=\"text-align: left;\">TTM P/E stands at <strong>28.36</strong>, which is elevated compared to its historical forward P/E average of <strong>16.35</strong>, indicating high expectations are priced in.</p>\n<p style=\"text-align: left;\"><strong>🎯 Analyst Targets:</strong></p>\n<p style=\"text-align: left;\"><strong>24 analysts</strong> cover JNJ with an average price target of <strong>$254.05</strong>. The consensus is bullish, with <strong>6 Strong Buy, 12 Buy, and 9 Hold</strong> ratings.</p>\n<p style=\"text-align: left;\"><strong>🔮 Weekly Outlook:</strong></p>\n<p style=\"text-align: left;\">Expect <strong>consolidation</strong> near current levels with a <strong>$240 - $252</strong> range. A decisive break above <strong>$251.71</strong> could target the <strong>$254-$260</strong> zone. A drop below <strong>$240</strong> may test the $233 support.</p>\n<p style=\"text-align: left;\"><strong>⚠️ Risk Disclaimer:</strong></p>\n<p style=\"text-align: left;\"><em>This analysis is for informational purposes only and not investment advice. Past performance does not guarantee future results. Always conduct your own research and consider your risk tolerance.</em></p></body></html>","text":"$Johnson & Johnson(JNJ)$ $Johnson & Johnson (JNJ) Climbs +1.61%: Healthcare Titan Gains Momentum, Eyes $254 Target 📈 Latest Close: JNJ closed at $244.88 (+1.61%) on 6/26, now just 2.7% away from its 52-week high of $251.71. 🚀 Core Market Drivers: Positive momentum is fueled by a favorable court ruling that halved talc-related damages to $2.1B, easing litigation overhang. Analyst sentiment remains strong, with Leerink Partners recently upgrading the stock to Outperform. 📊 Technical Analysis: Volume was 10.13M (Volume Ratio: 0.90). The MACD is bullish at 1.88, showing strong upward momentum. The RSI(6) is at 73.64, indicating overbought conditions in the short term, suggesting potential for a brief consolidation. 🎯 Key Price Levels: Immediate Pivot: $244.14 (Recent Resistance) Primary Support: $223.33 Strong Resistance: $251.71 (52-Week High) 💰 Valuation: TTM P/E stands at 28.36, which is elevated compared to its historical forward P/E average of 16.35, indicating high expectations are priced in. 🎯 Analyst Targets: 24 analysts cover JNJ with an average price target of $254.05. The consensus is bullish, with 6 Strong Buy, 12 Buy, and 9 Hold ratings. 🔮 Weekly Outlook: Expect consolidation near current levels with a $240 - $252 range. A decisive break above $251.71 could target the $254-$260 zone. A drop below $240 may test the $233 support. ⚠️ Risk Disclaimer: This analysis is for informational purposes only and not investment advice. Past performance does not guarantee future results. Always conduct your own research and consider your risk tolerance.","highlighted":1,"essential":1,"paper":2,"likeSize":81,"commentSize":0,"repostSize":3,"favoriteSize":0,"link":"https://ttm.financial/post/579376735567992","repostId":0,"isVote":1,"tweetType":1,"viewCount":196,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["JNJ"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":1339,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/579376735567992"}